BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Glamorous.AI

-X-Chem, the pioneer of DNA-encoded library (DEL) technology and a recognized leader in generating actionable results to drive small molecule drug discovery, announced the acquisition of Glamorous AI. GLAMOROUS AI has developed a novel approach to chemical design and optimization. Its proprietary platform, Rosalind, augments advanced ML with human expertise to enable applications where only limited data points are available.

Become a Member to view additional information about this company